Browse by Uncontrolled Keywords
Number of items: 6.
B
Burns, T;
Knapp, M;
Catty, J;
Healey, A;
Henderson, J;
Watt, H;
Wright, C;
(2001)
Home treatment for mental health problems: a systematic review.
Health technology assessment (Winchester, England), 5 (15).
pp. 1-139.
ISSN 1366-5278
https://researchonline.lshtm.ac.uk/id/eprint/15441
D
Dowie, J;
(2002)
Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions.
Health economics, 11 (1).
pp. 1-8.
ISSN 1057-9230
DOI: https://doi.org/10.1002/hec.667
Full text not available from this repository.
F
Fox-Rushby, JA;
Hanson, K;
(2001)
Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.
Health policy and planning, 16 (3).
pp. 326-31.
ISSN 0268-1080
https://researchonline.lshtm.ac.uk/id/eprint/16801
Full text not available from this repository.
G
Gilmore, A;
Milne, R;
(2001)
Methylphenidate in children with hyperactivity: review and cost-utility analysis.
Pharmacoepidemiology and drug safety, 10 (2).
pp. 85-94.
ISSN 1053-8569
DOI: https://doi.org/10.1002/pds.564
Full text not available from this repository.
S
Smith, RD;
Richardson, J;
(2005)
Can we estimate the 'social' value of a QALY? Four core issues to resolve.
Health policy (Amsterdam, Netherlands), 74 (1).
pp. 77-84.
ISSN 0168-8510
DOI: https://doi.org/10.1016/j.healthpol.2004.12.009
Full text not available from this repository.
W
Woodhall, SC;
Jit, M;
Cai, C;
Ramsey, T;
Zia, S;
Crouch, S;
Birks, Y;
Newton, R;
Edmunds, WJ;
Lacey, CJ;
(2009)
Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.
Sexually transmitted diseases, 36 (8).
pp. 515-21.
ISSN 0148-5717
DOI: https://doi.org/10.1097/OLQ.0b013e3181a74c2c
Full text not available from this repository.